CRISPR/Cas9 and ssODN used to repair the point mutation in A79V-hiPSC. A) Genomic sequence surrounding the mutation site: mutated nucleotide (T, red); sgRNA recognition site containing 20 bp (yellow); CRISPR cutting site between the 17th and 18th bp (bold); forward and reverse primers (pink). B) ssODN with 120 bp, 60 bp upstream and 60 bp downstream the mutation site containing the WT nucleotide (C, green).
Friday, June 19, 2020
CRISPR-U™ Point mutation Cell Line
Ubigene Biosciences, is a fast-growing company with an experienced team in gene-editing. Our advanced molecular and cell biology platform ensure us to provide high-quality services and products for biological research and biotechnology industries.
Subscribe to:
Post Comments (Atom)
[Research highlight] Enhancing p53 pathway can efficiently suppress colon cancer
Colorectal cancer is the third most diagnosed cancer and leads to the second mortality among cancers worldwide. The first-line chemotherap...
-
Background In 1996, U-87 MG cell line was isolat ed from the malignant glioma of a 44-year-old female patient. This human primary gliob...
-
Colorectal cancer is the third most diagnosed cancer and leads to the second mortality among cancers worldwide. The first-line chemotherap...
No comments:
Post a Comment